Corcept Therapeutics (CORT) Share-based Compensation (2010 - 2026)
Corcept Therapeutics recorded quarterly Share-based Compensation of $23.0 million in Q1 2026, up 10.95% quarter-over-quarter from $20.8 million in Q4 2025, and up 5.56% year-over-year from $21.8 million in Q1 2025.
Corcept Therapeutics' Share-based Compensation history runs 17 years deep, the most recent figure standing at $23.0 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 5.56% year-over-year to $23.0 million; the TTM figure through Mar 2026 stood at $85.7 million (up 22.56% YoY), while the FY2025 annual figure was $84.5 million, up 37.73% from the prior year.
- Share-based Compensation came in at $23.0 million for Q1 2026 at Corcept Therapeutics, up from $20.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $23.0 million in Q1 2026 to a low of $10.5 million in Q4 2022.
- A 5-year average of $15.3 million and a median of $13.2 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation slipped 4.17% in 2022 and soared 64.77% in 2025, its largest moves.
- Corcept Therapeutics' Share-based Compensation stood at $10.5 million in 2022, then increased by 24.18% to $13.1 million in 2023, then climbed by 28.56% to $16.8 million in 2024, then grew by 23.65% to $20.8 million in 2025, then increased by 10.95% to $23.0 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $23.0 million, $20.8 million, and $22.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | 23.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.04 Mn |
| Mar 31, 2026 | 23.04 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Sep 30, 2025 | 22.88 Mn |
| Sep 30, 2025 | 22.88 Mn |
| Jun 30, 2025 | 19.02 Mn |
| Jun 30, 2025 | 19.02 Mn |
| Mar 31, 2025 | 21.83 Mn |
| Mar 31, 2025 | 21.83 Mn |
| Dec 31, 2024 | 16.80 Mn |
| Dec 31, 2024 | 16.80 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | 15.21 Mn |
| Jun 30, 2024 | 15.21 Mn |
| Mar 31, 2024 | 13.25 Mn |
| Mar 31, 2024 | 13.25 Mn |
| Dec 31, 2023 | 13.07 Mn |
| Dec 31, 2023 | 13.07 Mn |
| Sep 30, 2023 | 12.88 Mn |
| Sep 30, 2023 | 12.88 Mn |
| Jun 30, 2023 | 11.86 Mn |
| Jun 30, 2023 | 11.86 Mn |
| Mar 31, 2023 | 11.14 Mn |
| Mar 31, 2023 | 11.14 Mn |
| Dec 31, 2022 | 10.52 Mn |
| Dec 31, 2022 | 10.52 Mn |
| Sep 30, 2022 | 10.55 Mn |
| Sep 30, 2022 | 10.55 Mn |
| Jun 30, 2022 | 10.61 Mn |
| Jun 30, 2022 | 10.61 Mn |
| Mar 31, 2022 | 10.76 Mn |
| Mar 31, 2022 | 10.76 Mn |
| Dec 31, 2021 | 10.81 Mn |
| Dec 31, 2021 | 10.81 Mn |
| Sep 30, 2021 | 10.95 Mn |
| Sep 30, 2021 | 10.95 Mn |
| Jun 30, 2021 | 11.07 Mn |
| Jun 30, 2021 | 11.07 Mn |
| Mar 31, 2021 | 10.10 Mn |
| Mar 31, 2021 | 10.10 Mn |
| Dec 31, 2020 | 8.43 Mn |
| Dec 31, 2020 | 8.43 Mn |
| Sep 30, 2020 | 8.70 Mn |
| Sep 30, 2020 | 8.70 Mn |
| Jun 30, 2020 | 8.49 Mn |
| Jun 30, 2020 | 8.49 Mn |
| Mar 31, 2020 | 7.92 Mn |
| Mar 31, 2020 | 7.92 Mn |
| Dec 31, 2019 | 7.61 Mn |
| Dec 31, 2019 | 7.61 Mn |
| Sep 30, 2019 | 7.27 Mn |
| Sep 30, 2019 | 7.27 Mn |
| Jun 30, 2019 | 7.74 Mn |
| Jun 30, 2019 | 7.74 Mn |
| Mar 31, 2019 | 6.70 Mn |
| Mar 31, 2019 | 6.70 Mn |
| Dec 31, 2018 | 6.27 Mn |
| Dec 31, 2018 | 6.27 Mn |
| Sep 30, 2018 | 6.51 Mn |
| Sep 30, 2018 | 6.51 Mn |
| Jun 30, 2018 | 6.02 Mn |
| Jun 30, 2018 | 6.02 Mn |
| Mar 31, 2018 | 4.95 Mn |
| Mar 31, 2018 | 4.95 Mn |
| Dec 31, 2017 | 3.83 Mn |
| Dec 31, 2017 | 3.83 Mn |
| Sep 30, 2017 | 3.62 Mn |
| Sep 30, 2017 | 3.62 Mn |
| Jun 30, 2017 | 3.21 Mn |
| Jun 30, 2017 | 3.21 Mn |
| Mar 31, 2017 | 2.70 Mn |
| Mar 31, 2017 | 2.70 Mn |
| Dec 31, 2016 | 1.96 Mn |
| Dec 31, 2016 | 1.96 Mn |
| Sep 30, 2016 | 1.83 Mn |
| Sep 30, 2016 | 1.83 Mn |
| Jun 30, 2016 | 1.66 Mn |
| Jun 30, 2016 | 1.66 Mn |
| Mar 31, 2016 | 1.61 Mn |
| Mar 31, 2016 | 1.61 Mn |
| Dec 31, 2015 | 1.49 Mn |
| Dec 31, 2015 | 1.49 Mn |
| Sep 30, 2015 | 1.54 Mn |
| Sep 30, 2015 | 1.54 Mn |
| Jun 30, 2015 | 1.57 Mn |
| Jun 30, 2015 | 1.57 Mn |
| Mar 31, 2015 | 1.41 Mn |
| Mar 31, 2015 | 1.41 Mn |
| Dec 31, 2014 | 1.39 Mn |
| Dec 31, 2014 | 1.39 Mn |
| Sep 30, 2014 | 1.21 Mn |
| Sep 30, 2014 | 1.21 Mn |
| Jun 30, 2014 | 1.23 Mn |
| Jun 30, 2014 | 1.23 Mn |
| Mar 31, 2014 | 1.38 Mn |
| Mar 31, 2014 | 1.38 Mn |
| Dec 31, 2013 | 1.31 Mn |
| Dec 31, 2013 | 1.31 Mn |
| Sep 30, 2013 | 1.31 Mn |
| Sep 30, 2013 | 1.31 Mn |
| Jun 30, 2013 | 1.27 Mn |
| Jun 30, 2013 | 1.27 Mn |
| Mar 31, 2013 | 1.31 Mn |
| Mar 31, 2013 | 1.31 Mn |
| Dec 31, 2012 | 1.05 Mn |
| Dec 31, 2012 | 1.05 Mn |
| Sep 30, 2012 | 993,000.00 |
| Sep 30, 2012 | 993,000.00 |
| Jun 30, 2012 | 882,000.00 |
| Jun 30, 2012 | 882,000.00 |
| Mar 31, 2012 | 2.39 Mn |
| Mar 31, 2012 | 2.39 Mn |
| Dec 31, 2011 | 1.03 Mn |
| Dec 31, 2011 | 1.03 Mn |
| Sep 30, 2011 | 954,000.00 |
| Sep 30, 2011 | 954,000.00 |
| Jun 30, 2011 | 869,000.00 |
| Jun 30, 2011 | 869,000.00 |
| Mar 31, 2011 | 580,000.00 |
| Mar 31, 2011 | 580,000.00 |
| Dec 31, 2010 | 585,000.00 |
| Dec 31, 2010 | 585,000.00 |
| Sep 30, 2010 | 545,000.00 |
| Sep 30, 2010 | 545,000.00 |
| Jun 30, 2010 | 502,000.00 |
| Jun 30, 2010 | 502,000.00 |